Hepatic Cirrhosis: A Literature Review
DOI:
10.29303/jbt.v24i1b.7801Published:
2024-12-07Downloads
Abstract
Hepatic cirrhosis is a chronic liver disease characterized by fibrosis and regeneration of nodules in the liver, which if it occurs for a long time, hepatocyte cells will be damaged so that they cannot function again, potentially threatening life. The prevalence of incidence and mortality depends on the progression of hepatic cirrhosis, which is influenced by the patient's etiology and treatment. The purpose of writing this article is to provide new insight into the importance of understanding the risk factor and causes of hepatic cirrhosis. This study uses a literature review approach by collecting data from online databases including Google Scholar, ProQuest, MDPI, and PubMed to search for articles discussing “Hepatic Cirrhosis”. Early detection based on clinical manifestations and appropriate treatment can reduce mortality and prevent complications that may worsen the patients condition.
Keywords:
Chronic, hepatic cirrhosis, liver disease.References
Alberts, C. J., Clifford, G. M., Georges, D., Negro, F., Lesi, O. A., Hutin, Y. J., & de Martel, C. (2022). Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. The Lancet Gastroenterology & Hepatology, 7(8), 724-735. 10.1016/S2468-1253(22)00050-4.
Amalia, M., Hidayati, P. H., Yanti, A. K. E., Vitayani, S., & Gayatri, S. W. (2023). Karakteristik Pasien Sirosis Hepatis. UMI Medical Journal, 8(1), 53-61.
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019). Burden of liver diseases in the world. Journal of hepatology, 70(1), 151-171.
Christian Yong, B. J. and Vidor, M. (2022) ‘Sirosis Hepatis - Reversibel atau Irreversibel?’, Cermin Dunia Kedokteran, 49(1), pp. 43–46. doi: 10.55175/cdk.v49i1.188.
Darni, Z. & Rahman, S. (2019) ‘Pelaksanaan Pengukuran Tanda-Tanda Vital pada Pasien Sirosis Hepatis untuk Mencegah Hipertensi Portal’, Jurnal Ilmiah Keperawatan Orthopedi, 3(2), pp. 47-54.
Dong, Y., Li, A., Zhu, S., Chen, W., Li, M., & Zhao, P. (2021). Biopsy‐proven liver cirrhosis in young children: A 10‐year cohort study. Journal of Viral Hepatitis, 28(6), 959-963. doi: 10.1111/jvh.13501.
Dwika, L. Y., Sukarno, A., Asmirajanti, M., & Abriyanti, R. M. (2022). A Studi Kasus Terapi Kombinasi Relaksasi Otot Progresif Dan Teknik Napas Dalam Terhadap Penurunan Nyeri Pasien Sirosis Hepatis Di RSUD TARAKAN. Alauddin Scientific Journal of Nursing, 3(1), 13-24. https://journal.uin-alauddin.ac.id/index.php/asjn/article/view/27867.
Hall, J. E. & Hall, M. E. (2021) Guyton and Hall Textbook of Medical Physiology. 14th edn. Philadelphia: Elsevier.
Jagdish, R. K., Roy, A., Kumar, K., Premkumar, M., Sharma, M., Rao, P. N., Reddy, D. N., & Kulkarni, A. V. (2023). Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure. Frontiers in medicine, 10, 1060073. https://doi.org/10.3389/fmed.2023.1060073
Jain, P. et al. (2021) ‘Correlation of aspartate aminotransferase-to-platelet rasio index with child-turcotte-pugh score and model for end stage liver disease score in patient of liver cirrhosis’, International Journal of Advances in Medicine, 8(10), pp. 1544-1550. https://www.ijmedicine.com.
Kementerian Kesehatan RI (2022) Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/1355/2022 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Karsinoma Sel Hati pada Dewasa.
Kitajima, Y., Takahashi, H., Akiyama, T., Murayama, K., Iwane, S., Kuwashiro, T., ... & Eguchi, Y. (2018). Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. Journal of gastroenterology, 53, 427-437. 10.1007/s00535-017-1370-x.
Lee, N. Y. and Suk, K. T. (2021) ‘The role of the gut microbiome in liver cirrhosis treatment’, International Journal of Molecular Sciences, 22(1), pp. 1–16. doi: 10.3390/ijms22010199.
Lee S, Saffo S. Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy. World J Gastroenterol. 2023 Jan 7;29(1):61-74. doi: 10.3748/wjg.v29.i1.61. PMID: 36683719; PMCID: PMC9850948.
Liu, Y. & Chen, M. (2022) ‘Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions’, World Journal of Gastroenterology, 28(41), pp. 5910-5930. doi: 10.3748/wjg.v28.i41.5910.
Mitra, M. & Swaminathan, A. (2022) ‘The Molecular and Cellular Underpinnings of Cirrhosis of the Liver’, Journal of Student Research, 11(2), pp. 1-17.
Moon, A. M, Singal, A. G., & Tapper, E. B. (2020) ‘Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis’, Clinical Gastroenterology and Hepatology, 18(12), pp. 2650-2666. doi: 10.1016/j.cgh.2019.07.060.
National Institute of Diabetes and Digestive and Kidney Diseases (2018). “Cirrhosis”. https://www.niddk.nih.gov/health-information/liver-disease/cirrhosis
Ndraha, S. et al. (2018) ‘Komplikasi Penderita Sirosis Hati Di RSUD KOJA Pada Bulan Juli - November 2017’, Jurnal Kedokteran Meditek, 24(67), pp. 17–20. doi: 10.36452/jkdoktmeditek.v24i67.1590.
Perez IC, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med. 2021 May 25;13:45-57. doi: 10.2147/HMER.S278032. PMID: 34079394; PMCID: PMC8164676.
Ruiz-Margáin, A., Macías-Rodríguez, R. U., Ríos-Torres, S. L., Román-Calleja, B. M., Méndez-Guerrero, O., Rodríguez-Córdova, P., & Torre, A. (2018). Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Revista de Gastroenterología de México (English Edition), 83(1), 9-15. 10.1016/j.rgmx.2017.02.005.
Setiawan, D., Arisandi, D., & Trisnawati, L. (2022) ‘Aplikasi Prediksi Penyakit Sirosis Hati Menggunakan Algoritma Genetika’, Jurnal SANTI (Sistem Informasi dan Teknologi Informasi), 2(1), pp. 31-40.
Sharma, B., John, S. (2022) Hepatic Cirrhosis. StatPearls Publishing [serial online]. [cited 2024 September 18]. Available from:https://www.ncbi.nlm.nih.gov/books/NBK482419/
Shrestha, A., Khadka, D., & Shrestha, R. (2018) ‘Correlation of Grading of Esophageal Varices with Child Turcotte Pugh Class in Patients of Liver Cirrhosis’, Journal of Nepalgunj Medical College, 16(2), pp. 50-53.
Smith, A., Baumgartner, K., & Bositis, C. (2019). Cirrhosis: Diagnosis and Management. American Family Physician, 100(12), pp. 759–770.
Sulistyoningrum, E. & Murtisiwi, L. (2020) ‘Gambaran Peresepan Pasien Sirosis Hati di Instalasi Rawat Jalan Rumah Sakit Panti Waluyo Surakarta’, Journal of Pharmacy, 9(1), pp. 1-7. doi: 10.37013/jf.v9i1.96.
Thaha, R., Yunita, E. and Sabir, M. (2020) ‘Sirosis Hepatis’, Jurnal Medical Profession (MedPro), 2(3), pp. 166–171.
The Korean Association for the Study of the Liver (KASL) (2018) ‘KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications’, Clinical and Molecular Hepatology, 24, pp. 230-277. doi: 10.3350/cmh.2018.1005.
Vaz, J., Eriksson, B., Strömberg, U., Buchebner, D., & Midlöv, P. (2020). Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC gastroenterology, 20, 1-8. 10.1186/s12876-020-01239-6.
Virma, S. G., Adelin, P., & Mona, L. (2023) ‘Karakteristik Pasien Sirosis Hepatis di Rumah Sakit Dr. Achmad Mochtar Bukittinggi Periode Tahun 2018-2020’, Jurnal Kedokteran Nanggroe Medika, 6(1), pp. 1-8.
Yoshiji, H. et al. (2021) ‘Evidence-based clinical practice guidelines for Liver Cirrhosis 2020’, Journal of Gastroenterology, 56(7), pp. 593–619. doi: 10.1007/s00535-021-01788-x.
Zhai, M., Long, J., Liu, S., Liu, C., Li, L., Yang, L., ... & Shu, B. (2021). The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY), 13(1), 279. https://www.aging-us.com.
License
Copyright (c) 2024 Komang Puspa Dewi, Aisya Nur Abida, Alifa Aswandani, Baiq Annisa Ulfi Anggraeni, Dhiya Atsila Shofa, Muhammad Rezky Audia Aunurrahman, Najla Firyal Husna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
